nternal Haemorrhoids has been the most common disease since ages and wide variety of treatment modalities available make it an equally enigmatic disease to approach. Polidocanol is the recent sclerosants in the surgeon’s armamentarium for its treatment. This prospective study included 86 patients with first or second degree internal haemorrhoids. Internal haemorrhoids had sexual predilection towards males in our study in the ratio of 2:1 with a age range of 24-68 yrs. Sixty-one of 86 patients had first degree haemorrhoids and the rest 25 had second degree. Bleeding P/R was the most common complaint followed by constipation and perianal discomfort. Response to first dose of 3% polidocanol was seen in 59.3% of patients, 29.07% patient responded to second dose and 11.63% patients responded to the third dose of sclerotherapy. Sclerotherapy is an effective option in the treatment of first and second degree haemorrhoids and 3% polidocanol has been an effective agent in this strategy.

Keywords: Internal haemorroids; Injection sclerotherapy; 3% polidocanol.